Nice one, renewed license. Wonder how close they came to loosing it? Oh well that is a major relief. Hope the share price can start to move now. Come on with the new figures already!
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
